Trial Profile

Phase 1 clinical study assessing ZW209

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 04 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ZW 209 (Primary)
Indications Cancer
Focus Adverse reactions

Most Recent Events

11 Jan 2026 According to a Zymeworks media release, IND submissions for ZW209 remain on track for 2026, as the company continues to evaluate partnership opportunities ahead of initiating clinical studies.
19 Dec 2024 New trial record
12 Dec 2024 According to Zymeworks media release, the company expects to submit an IND and non-U.S. applications to commence Phase 1 clinical studies for ZW209 in 1H-2026.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com